Related Experiment Video
Updated: May 27, 2026
02:26
Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
TRPA1 antagonists as potential analgesic drugs
E L Andrade1, F C Meotti, J B Calixto
1Departamento de Farmacologia, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, Brazil.
Pharmacology & Therapeutics
|November 29, 2011
Summary
The transient receptor potential ankyrin 1 (TRPA1) channel is crucial for pain and sensation. Targeting TRPA1 offers a promising avenue for developing novel analgesic drugs to treat chronic pain conditions.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Chronic pain necessitates novel analgesic treatments.
- Transient Receptor Potential (TRP) ion channels, including TRPA1, are increasingly recognized for their roles in physiological and pathological processes.
- TRPA1 is a cation channel expressed in sensory neurons, involved in detecting various stimuli and pain transmission.
Purpose of the Study:
- To review the role of TRPA1 activation and blockade in pain transmission.
- To explore the mechanisms of TRPA1 activation and modulation by different stimuli.
- To discuss advancements in TRPA1-targeted analgesic drug discovery.
Main Methods:
- Literature review of studies on TRPA1 function in pain.
- Analysis of research on TRPA1 activation and modulation mechanisms.
- Synthesis of current findings on TRPA1 as a therapeutic target.
Main Results:
- TRPA1 plays a significant role in inflammatory and neuropathic pain.
- Evidence supports TRPA1's involvement in pain transmission, though its role in cold sensation is debated.
- Various exogenous and endogenous stimuli modulate TRPA1 activity.
Conclusions:
- TRPA1 is a key player in somatosensation and nociception.
- Modulating TRPA1 activity presents a viable strategy for developing new pain therapies.
- Further research into TRPA1 mechanisms can accelerate the development of effective analgesics.
Related Concept Videos
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:28Drug-Receptor Interaction: Antagonist
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:43Thermosensation
Peripheral thermosensation is the perception of external temperature. A change in temperature (on the surface of the skin and other tissues) is detected by a family of temperature-sensitive ion channels called Transient Receptor Potential, or TRP, receptors. These receptors are located on free nerve endings. Those detecting cold temperatures are closer to the surface of the skin than the nerve endings detecting warmth. These thermoTRP channels, while temperature selective, have relatively...